Bioinformatics Services Market Size & Share 2023 to 2032

Bioinformatics Services Market Size

Bioinformatics Services Market size was valued at USD 2.8 billion in 2022 and is anticipated to reach an estimated value of USD 12 billion by 2032 growing at a CAGR of 15.9%. The market is primarily driven by rapid advancements in genomic sequencing technologies. The continuous evolution of high-throughput sequencing platforms results in large genomic data generation.

For instance, recent NGS technology breakthrough, such as the iSeq 100 system by Illumina, combines a complementary metal-oxide semiconductor (CMOS) chip with one-channel SBS to deliver high-accuracy in a short period of time, generating vast amount of data. As a result, there is a growing need for sophisticated bioinformatics services to analyse and interpret this vast amount of genetic information, thereby fostering market share.
 

Bioinformatics services refer to a range of computational and analytical services that support research and analysis in the field of bioinformatics. Bioinformatics is an interdisciplinary field that combines biology, computer science, and statistics to analyse and interpret biological data, particularly data related to DNA, RNA, and protein sequences. The services play a crucial role in various areas of biology and biomedical research, including genomics, proteomics, structural biology, and more.
 

COVID-19 Impact

The COVID- 19 pandemic had a positive impact on the bioinformatics services market. The pandemic significantly accelerated the demand for bioinformatics services as researchers worldwide raced to analyse and interpret genomic data related to the virus. This surge in genomic research, coupled with the growing need for remote collaborations and data sharing, drove the market to expand rapidly. Additionally, increased investments in cloud-based solutions and data analytics tools to support the global scientific response to the pandemic, further accelerated the market progress in 2020.
 

Bioinformatics Services Market Trends

• Government fundings and collaborative research initiatives have emerged as crucial drivers for the market. For instance, in 2019, NIH granted approximately USD 29.5 million funds for advancing sequencing and bioinformatics technology for human genome.
   
• Similarly, in 2019, the Rockefeller Foundation announced over USD 20 million in funding and several non-financial collaborations to help strengthen global capabilities in genomic sequencing & data sharing.
   

These investments provided essential resources for researchers and companies, thereby aiding in market growth. Moreover, collaborative efforts among academic institutions, research organizations, and industry players have also intensified, leading to the creation of diverse datasets and the need for bioinformatics services to analyse and interpret these data.
 

• Furthermore, the increasing demand for precision medicine is a significant driver for the market.
   
• For instance, 12 new drugs identified as personalized medicines were approved in 2022 by FDA, which represented about 34% of all newly approved drugs. Personalized medicine relies on the analysis of an individual's genetic makeup to tailor medical treatments and therapies.
   

As this approach gains prominence in healthcare, bioinformatics plays a pivotal role in deciphering genetic data to guide treatment decisions. Thus, increasing focus on personalized medicine is expected to continue driving the market demand.
 

Bioinformatics Services Market Analysis

By type, the bioinformatics services market is segmented into sequencing services, data analysis, drug discovery services, differential gene expression analysis, database management services, and other bioinformatics services. The sequencing services segment is anticipated to grow at 15.4% CAGR over the coming years. High segmental share can be attributed to the rapid advancements in genomics research, personalized medicine, and biotechnology.
 

• Researchers, pharmaceutical companies, and healthcare institutions are increasingly relying on next-generation sequencing (NGS) technologies to decipher the genetic information of organisms, identify disease-causing mutations, and develop targeted therapies.
   
• As a result, the market is experiencing unprecedented growth as organizations seek expertise to manage, analyse, and interpret the vast amounts of genomic data generated through these sequencing technologies. Thus, increased demand for such services is expected to spur the segment expansion.
   

Learn more about the key segments shaping this market

Download Free PDF

By application, the bioinformatics services market is segmented into genomics, proteomics, chemoinformatics & drug design, pharmacogenomics, transcriptomics, metabolomics, and other applications. The genomics segment is anticipated to reach USD 4.6 billion by 2032.
 

• The genomics segment in the market has experienced remarkable growth in recent years. This surge can be attributed to increased availability of genomic data, advancements in sequencing technologies, and a growing awareness of the potential applications of genomics in healthcare.
   
• Furthermore, as researchers and organizations strive to unlock the vast potential of genomics data, the demand for bioinformatics services has surged, further propelling the market trends.
   

Based on end-use, the bioinformatics services market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical and biotechnology companies, Contract Research Organization (CROs), and other end-users. Academic institutes & research centers segment dominated the market with a market share of 42.5% in 2022. Their dominance stems from their critical role in advancing the field of life sciences through cutting-edge research and education.
 

• Academic institutes & research centers rely heavily on bioinformatics services to analyse vast amounts of biological data, facilitating discoveries in genomics, proteomics, and drug development.
   
• With their substantial budgets and focus on interdisciplinary research, academic institutes and research centers continue to be key drivers of innovation in the bioinformatics industry, thereby aiding in high segment growth.
   

North America dominated the bioinformatics services market in 2022 with a market share of 45.5% and is expected to grow at a CAGR of 16.1% between 2023 - 2032.
 

• The high growth can be attributed to a confluence of factors, including robust investment in research and development, presence major market player and a strong emphasis on personalized medicine.
   
• Additionally, substantial investments and fundings to support drug discovery, disease diagnosis, and genomic research has further accelerated the regional market growth.
   
• As the region continues to lead in genomics and life sciences fields, the growth of the market is anticipated to continue over the analysis years.
   

Bioinformatics Services Market Share

The industry leaders operating in this market have established themselves through innovation, service quality, and a strong market presence. Illumina, BGI, QIAGEN N.V., and Thermo Fisher Scientific, Inc. are significant players in this market and accounts for largest market share. These prominent players offer a wide range of bioinformatics services catering to the vast need of healthcare industry.
 

Market players operating in the bioinformatics services industry is as mentioned below:

• Illumina, Inc.
• BGI
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Eurofins Scientific
• NeoGenomics
• CD Genomics
• Macrogen
• QIAGEN (QIAGEN N.V.)
• GENEWIZ
• Source BioScience
• Microsynth
• MedGenome
• Fios Genomics
• BaseClear
   

Bioinformatics Services Industry News:

• In January 2022, Illumina, Inc. launched a new bioinformatics solution, Illumina Connected Analytics (ICA). This new and integrated bioinformatics solution provides a comprehensive, private, cloud-based data platform that empowers customers to manage, analyze, and explore large volumes of multi-omic data in a secure, scalable, and flexible environment. This helped the company to widen its services portfolio.
   
• In January 2020, Charles River Laboratories International, Inc. signed an exclusive partnership with Fios Genomics to provide bioinformatics-driven drug discovery and safety assessment. This strategy helped the company to increase revenue generation.
   

The bioinformatics services market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

Click here to Buy Section of this Report

By Type, 2018 – 2032 (USD Million)

• Sequencing services
• Data analysis
• Drug discovery services
• Differential gene expression analysis
• Database management services
• Other bioinformatics services

By Application, 2018 – 2032 (USD Million)

• Genomics
• Proteomics
• Chemoinformatics & drug design
• Pharmacogenomics
• Transcriptomics
• Metabolomics
• Other applications

By End-use, 2018 – 2032 (USD Million)

• Academic institutes & research centers
• Hospitals & clinics
• Pharmaceutical and biotechnology companies
• Contract Research Organization (CROs)
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA